Burson-Marsteller scoops local PR duties for Cenovis Chill Pill in Australia

BM will be overseeing the local Australian communications business for Chill Pill, which is part of the latest product range from sub-brand Cenovis under Sanofi-Aventis Consumer Healthcare.

The public relations agency will take responsibility for adapting Chill Pill’s current radio marketing campaign to a broader television, print and online project. The aim is to position Chill Pill as a medium for a wider range of stressful situations in Australians' every day lives. 

“Australians continue to take a growing interest in their health, and this includes the use of natural health supplements. We are excited to be working with the Cenovis team as we look to increase the range of options for consumers who want to improve their day-to-day wellbeing,” said Brian West, market leader at Burson-Marsteller

Reported this month, Sanofi-Aventis also appointed Hill & Knowlton to manage communications for the Cenovis account in Asia-Pacific.

Other news for BM include the appointment of Katie Dufficy as associate of technology practice. Her responsibilities include planning, implementing and delivering results on PR strategies in the Australian and New Zealand markets. She will also focus on social media campaigns, analyst relations programmes and large-scale media events.

Dufficy joins from N2n Communications.